BridgeBio has substantially boosted this progress of an new treatment for ATTR-CM, utilizing the investigational drug. Initial trial data reveals potential benefits for patients affected with the severe condition. The effort underscores researchers’ commitment to managing unmet patient needs in a heart disease field. Attruby: BridgeBio'… Read More